CEPI on Mythryl: “A landmark new CEPI-funded trial has launched in Ghana assessing the…”

A landmark new CEPI-funded trial has launched in Ghana assessing the @ox.ac.uk’s promising vaccine candidate against Lassa fever, the deadly disease which affects hundreds of thousands across West Africa each year. cepi.net/first-partic...

cepi.netFirst participants vaccinated with Oxford's CEPI-backed Lassa shot in GhanaThe study will provide additional data on the investigational shot, ChAdOx1 LassaJ.

16/10/26, 4:22 pm0 reposts4 likes

Post